Header image

CELI•VITES Bone Health

Bone Health by Celi•Vites includes:

  • 180mcg of Vitamin K2 as menaquinone-7 (MK-7)
  • Aquamin®, a highly absorbable plant-based source of calcium
  • Balanced proportions of magnesium and potassium citrate
  • 1000 IU of Vitamin D3
  • Delightful orange flavor  simply add powder to juice or water



Product Description

The CELI•VITES Bone Health Formula supports the skeleton on multiple levels. It contains Aquamin®, a highly absorbable, plant-based source of calcium, vitamin D3, magnesium and potassium. Celi•Vites is unique among bone health supplements because it also provides vitamin K2 (menaquinone-7), in a dose clinically proven to reduce bone loss in postmenopausal women*. Like all Celi•Vites supplements, nutrients in Bone Health are provided in a readily bioavailable form for maximum absorption and utilization.

*Knapen M.H.J., et al. (2013) Three-year low-dose meanquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women. Osteoporos Int9:2499-507. PMID:23525894


There are no reviews yet.

Be the first to review “CELI•VITES Bone Health”

Supplemental Facts Image

Each ingredient contained within the Celi•Vites supplements was purposefully selected. To learn more about each ingredient, click the tabs below.

Vitamin D3

Bone Health by Celi•Vites provides 1000 IU or 250% of the daily value of vitamin D. Those taking both Body Health and Bone Health by Celi•Vites will receive 2000 IU or 500% of the daily value for Vitamin D. In a controlled experiment using laboratory non-human primate models of postmenopausal women, those with higher serum concentrations of vitamin D and also receiving supplemental estrogen had increased bone density relative to those receiving a placebo instead of estrogen. In summary, in this study vitamin D and estrogen supplementation are synergistic in their effects on increased bone mineral density*.

*Schnatz P.F. et al. (2012) Response to an adequate dietary intake of vitamin D3 modulates the effect of estrogen therapy on bone density. J Women’s Health (Larchmt) 8:858-64. PMID: 22691032

Vitamin K2

In a clinical study, postmenopausal women taking 180mcg of Vitamin K2 as menaquinone-7, the same dose provided by Bone Health by Celi•Vites, had decreased bone loss*.

In a prospective study of 4807 Dutch men and women over age 55, those ingesting quantities of menaquinone in the mid and upper tertiles (21.6-32.7 and >32.7 mcg respectively) had a decreased risk of dying from coronary heart disease, a decreased risk of dying from any cause, and a decreased risk of severe coronary calcification**.

*Knapen M.H.J., et al. (2013) Three-year low-dose meanquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women. Osteoporos Int. 9:2499-507. PMID:23525894

**Geleijnse, J.M., et al. (2004) Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study. J Nutr. 134:3100-5. PMID: 15514282


Fifty percent of the calcium in Bone Health by Celi•Vites is supplied as calcium citrate and 50% as Aquamin®, which is derived from Litothamnion coralliodes, a red algae from the Atlantic waters off the coast of Ireland and Iceland. Aquamin® was found to reverse bone loss associated with feeding a high-fat Western diet in female mice*. As a marine plant-derived extract, in addition to calcium, Aquamin® contains magnesium and over 70 trace and ultra-trace minerals.

*Aslam M.N. et al. (2010) A Mineral-Rich Extract from the Red Marine Algae Lithothamnion calcareum Preserves Bone Structure and Function in Female Mice on a Western-Style Diet. Calcif Tissue Int 86:313-24. PMID: 20180099

Magnesium citrate

Magnesium is important for calcium homeostatis and bone health. In a prospective study of 20 postmenopausal osteoporotic women, those taking a supplement with 1830mg magnesium citrate had levels of biochemical markers indicative of less of bone turnover than those not taking the supplement*.

*Aydin, H. et al. (2010) Short-term oral magnesium supplementation suppresses bone turnover in postmenopausal osteoporotic women. Biol Trace Elem Res 133:136-43. PMID: 19488681

Potassium citrate

The western diet is higher in meats and high protein grains than was the diet of our ancestors, resulting in acidification. One hypothesis is that such an increase in acid load contributes to the loss in bone mineral density observed among modern postmenopausal women. Because potassium citrate is alkalizing, it could reverse the effects of an increased acid load on bone formation or loss. In a study with 161 postmenopausal women with low bone mass, when compared with those given potassium chloride, those given potassium citrate gained bone mineral density in the lumbar spine after 12 months (L2 - L4) (P<0.001)*.

In the U.S. 98% of adults do not ingest the recommended daily value of potassium (4700 mg)**.

*Jehle S. et al. (2006) Partial neutralization of the acidogenic Western diet with potassium citrate increased bone mass in postmenopausal women with osteopenia. J Am Soc Nephrol 17:3213-3222. PMID:17035614

**Cogswell M.E. et al. (2012) Sodium and potassium intakes among US adults: NHANES 2003-2008. Am J Clin Nutr 96:647-57. PMID:22854410